CN Patent

CN105213372A — S1p受体激动剂的给药方案

Assigned to Novartis AG · Expires 2016-01-06 · 10y expired

What this patent protects

本发明涉及S1P受体激动剂的给药方案，包括将S1P受体调节剂或激动剂以其中治疗的起始阶段的每日剂量低于标准每日剂量的给药方案进行给药。

USPTO Abstract

本发明涉及S1P受体激动剂的给药方案，包括将S1P受体调节剂或激动剂以其中治疗的起始阶段的每日剂量低于标准每日剂量的给药方案进行给药。

Drugs covered by this patent

Patent Metadata

Patent number
CN105213372A
Jurisdiction
CN
Classification
—
Expires
2016-01-06
Drug substance claim
No
Drug product claim
No
Assignee
Novartis AG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.